{"id":7765,"date":"2026-04-30T08:56:04","date_gmt":"2026-04-30T05:56:04","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=7765"},"modified":"2026-04-30T08:58:30","modified_gmt":"2026-04-30T05:58:30","slug":"inesss-rejects-vamorolone-agamree-reimbursement","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/inesss-rejects-vamorolone-agamree-reimbursement\/","title":{"rendered":"Vamorolone (Agamree) INESSS Taraf\u0131ndan Reddedildi: DMD Bak\u0131m\u0131nda Maliyetin, Merhametin \u00d6n\u00fcne Ge\u00e7mesinin Sonucu"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Kanada&#039;daki INESSS&#039;in (Institut national d&#039;excellence en sant\u00e9 et en services sociaux) Agamree (vamorolone) i\u00e7in geri \u00f6demeyi reddetme karar\u0131, b\u00fcrokratik bir sonu\u00e7tan daha fazlas\u0131n\u0131 temsil ediyor; ekonomik modelleri Duchenne kas distrofisi (DMD) ile ya\u015fayan \u00e7ocuklar\u0131n acil ihtiya\u00e7lar\u0131yla dengelemede sistemik bir ba\u015far\u0131s\u0131zl\u0131\u011f\u0131 ortaya koyuyor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Bilinen Bir Hastal\u0131k, Bilinen Bir \u0130htiya\u00e7<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">DMD, \u00f6nemsiz bir hastal\u0131k de\u011fildir. Nadir g\u00f6r\u00fclen, ilerleyici ve \u00f6l\u00fcmc\u00fcl bir n\u00f6rom\u00fcsk\u00fcler bozukluk olup, yakla\u015f\u0131k 4700 erkek \u00e7ocu\u011fundan birini etkiler; hastalar\u0131n \u00e7o\u011fu ergenlik d\u00f6neminde y\u00fcr\u00fcme yetene\u011fini kaybeder ve 20&#039;li veya 30&#039;lu ya\u015flar\u0131n\u0131n ba\u015flar\u0131nda \u00f6l\u00fcr.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Standart tedaviler\u2014ba\u015fta prednizon ve deflazakort gibi kortikosteroidler olmak \u00fczere\u2014etkilidir ancak bir maliyeti vard\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>b\u00fcy\u00fcme bask\u0131lanmas\u0131<\/li>\n\n\n\n<li>davran\u0131\u015f bozukluklar\u0131<\/li>\n\n\n\n<li>osteoporoz ve k\u0131r\u0131klar<\/li>\n\n\n\n<li>metabolik komplikasyonlar<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Daha g\u00fcvenli alternatiflere duyulan ihtiya\u00e7 varsay\u0131msal de\u011fil, acil ve iyi belgelenmi\u015f bir ger\u00e7ektir. Daha fazla bilgi edinin: <a href=\"https:\/\/dmdwarrior.com\/tr\/pros-and-cons-of-steroids-for-duchenne-muscular-dystrophy\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne Kas Distrofisi \u0130\u00e7in Steroidlerin (Kortizon) Art\u0131lar\u0131 ve Eksileri<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Agamree Ger\u00e7ekte Ne Sunuyor?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>INESSS&#039;in kendisi de vamorolonun tedavi edici de\u011ferinin oldu\u011funu kabul etmektedir.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Klinik bulgular \u015funlar\u0131 g\u00f6stermektedir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Motor fonksiyonlarda (\u00f6rne\u011fin, 6MWT, TTSTAND) plaseboya k\u0131yasla istatistiksel olarak anlaml\u0131 iyile\u015fme.<\/li>\n\n\n\n<li>Prednizona benzer etkinlik.<\/li>\n\n\n\n<li>Potansiyel g\u00fcvenlik avantajlar\u0131:\n<ul class=\"wp-block-list\">\n<li>Daha az davran\u0131\u015fsal yan etki (20%&#039;ye kar\u015f\u0131 32%)<\/li>\n\n\n\n<li>daha iyi b\u00fcy\u00fcme sonu\u00e7lar\u0131<\/li>\n\n\n\n<li>k\u0131r\u0131k riskinin azalmas\u0131na dair sinyaller<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu ba\u015far\u0131s\u0131z bir ila\u00e7 de\u011fil.<br><strong>Bu, klinik olarak do\u011frulanm\u0131\u015f ve g\u00fcvenlik a\u00e7\u0131s\u0131ndan \u00f6nemli iyile\u015ftirmeler i\u00e7eren bir alternatiftir.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Reddedilmenin Ger\u00e7ek Nedeni: Fiyat<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">INESSS, Agamree&#039;yi i\u015fe yaramad\u0131\u011f\u0131 i\u00e7in reddetmedi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bunu \u015fu nedenlerle reddettiler:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hasta ba\u015f\u0131na y\u0131ll\u0131k maliyet: <strong>~$65.000 ile $125.000 aras\u0131<\/strong><\/li>\n\n\n\n<li>Maliyet-etkinlik oran\u0131:<br><strong>$2,217,370 QALY ba\u015f\u0131na (Ya\u015fam Kalitesine G\u00f6re Ayarlanm\u0131\u015f Ya\u015fam Y\u0131l\u0131)<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Kabul edilebilir e\u015fiklere ula\u015fmak i\u00e7in:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fiyat\u0131n d\u00fc\u015fmesi gerekecek <strong>96\u201398%<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">En iyimser varsay\u0131mlar alt\u0131nda bile:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hala <strong>$312,142 QALY ba\u015f\u0131na<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Sonu\u00e7:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">\u201cMaliyet-fayda oran\u0131 makul de\u011fil.\u201d<\/p>\n<\/blockquote>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">INESSS&#039;in Yetersiz Kald\u0131\u011f\u0131 Noktalar<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ekonomik a\u00e7\u0131dan tutarl\u0131 olsa da, bu karar etik a\u00e7\u0131dan kritik k\u00f6r noktalar\u0131 ortaya koyuyor.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. Maliyet-Etkinlik Modellerine A\u015f\u0131r\u0131 G\u00fcvenme<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>QALY tabanl\u0131 \u00e7er\u00e7eveler sistematik olarak \u015fu ki\u015fileri dezavantajl\u0131 duruma d\u00fc\u015f\u00fcrmektedir:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>nadir hastal\u0131klar<\/li>\n\n\n\n<li>\u00e7ocuk pop\u00fclasyonlar\u0131<\/li>\n\n\n\n<li>iyile\u015ftirici olmayan tedaviler<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu modeller \u015fu hususlar\u0131 yakalayam\u0131yor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>bak\u0131m veren y\u00fck\u00fcn\u00fcn azalt\u0131lmas\u0131<\/li>\n\n\n\n<li>uzun s\u00fcreli sakatl\u0131k maliyet dengelemeleri<\/li>\n\n\n\n<li>\u00e7ocuklarda ya\u015fam kalitesi n\u00fcanslar\u0131<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">2. Kademeli G\u00fcvenlik Kazan\u0131mlar\u0131n\u0131 G\u00f6z Ard\u0131 Etmek<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>DMD&#039;de g\u00fcvenlik alan\u0131ndaki m\u00fctevaz\u0131 iyile\u015ftirmeler bile b\u00fcy\u00fck \u00f6nem ta\u015f\u0131r:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Daha az k\u0131r\u0131k \u2192 daha az hastaneye yat\u0131\u015f<\/li>\n\n\n\n<li>daha iyi b\u00fcy\u00fcme \u2192 uzun vadeli kalk\u0131nma etkisi<\/li>\n\n\n\n<li>Davran\u0131\u015fsal toksisitenin azalmas\u0131 \u2192 aile istikrar\u0131<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">INESSS bunlar\u0131 kabul ediyor, ancak ekonomik olarak \u00f6nemsiz g\u00f6r\u00fcyor.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3. E\u015fitlik ve Verimlilik \u00c7at\u0131\u015fmas\u0131<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Kararda \u00f6rt\u00fcl\u00fc olarak \u015fu ifade yer almaktad\u0131r:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">\u201cBu ila\u00e7 i\u015fe yar\u0131yor, ancak fiyat\u0131n\u0131 hakl\u0131 \u00e7\u0131karacak kadar etkili de\u011fil.\u201d<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00d6l\u00fcmc\u00fcl bir hastal\u0131\u011f\u0131 olan \u00e7ocuklar i\u00e7in bu, tarafs\u0131z bir a\u00e7\u0131klama de\u011fil; yeniliklere e\u015fit eri\u015fimin reddedilmesidir.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Santhera da E\u015fit Derecede \u0130ncelemeyi Hak Ediyor<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ele\u015ftiriler INESSS ile s\u0131n\u0131rl\u0131 kalmamal\u0131.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00dcretici firma Santhera&#039;n\u0131n \u00f6nemli bir sorumlulu\u011fu bulunmaktad\u0131r.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Agamree&#039;nin fiyat\u0131 \u015fu \u015fekildedir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>\u00c7ocuk ba\u015f\u0131na y\u0131lda 125.000 Amerikan Dolar\u0131<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u2026\u015fu hastal\u0131kta:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>tedavisi yok<\/li>\n\n\n\n<li>s\u0131n\u0131rl\u0131 alternatifler<\/li>\n\n\n\n<li>y\u00fcksek kar\u015f\u0131lanmam\u0131\u015f ihtiya\u00e7<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u2026ciddi etik kayg\u0131lar do\u011furuyor.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Fiyatland\u0131rma Sorunu<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">INESSS&#039;in tahminlerine g\u00f6re, kabul edilebilir e\u015fiklere ula\u015fmak i\u00e7in:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Gerekli fiyat indirimi: <strong>85%\u201398%<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu, k\u00fc\u00e7\u00fck \u00e7apl\u0131 bir fiyatland\u0131rma hatas\u0131 de\u011fil.<br><strong>Bu, sistemik a\u015f\u0131r\u0131 fiyatland\u0131rmad\u0131r.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">K\u00fcresel Sorumluluk<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>DMD k\u00fcresel bir hastal\u0131kt\u0131r.<br><\/strong>Eri\u015fimdeki e\u015fitsizlikler sadece ekonomik de\u011fil, ayn\u0131 zamanda ahlakidir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Fiyatland\u0131rmada de\u011fi\u015fiklik olmazsa:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Y\u00fcksek gelirli \u00fclkeler teredd\u00fct edecekler.<\/li>\n\n\n\n<li>Orta ve d\u00fc\u015f\u00fck gelirli \u00fclkeler tamamen kapsam d\u0131\u015f\u0131nda b\u0131rak\u0131lacakt\u0131r.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu, iki kademeli bir sistem olu\u015fturur:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Baz\u0131 \u00e7ocuklar daha g\u00fcvenli terapiye eri\u015febilir<\/li>\n\n\n\n<li><strong>Di\u011ferleri ise daha eski ve daha zehirli ila\u00e7lar kullanmaya devam eder<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu sonu\u00e7 savunulamaz.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Neler De\u011fi\u015fmeli?<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">INESSS ve d\u00fczenleyici kurumlar i\u00e7in:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Nadir hastal\u0131klara \u00f6zg\u00fc de\u011ferlendirme \u00e7er\u00e7evelerini dahil edin.<\/strong><\/li>\n\n\n\n<li>\u00c7ocuklarda \u00f6l\u00fcmc\u00fcl hastal\u0131klara ili\u015fkin maliyet-etkinlik e\u015fiklerini ayarlay\u0131n.<\/li>\n\n\n\n<li><strong>Kademeli g\u00fcvenli\u011fi y\u00fcksek de\u011fer olarak kabul edin.<\/strong><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Santhera i\u00e7in:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>K\u00fcresel \u00e7apta fiyat indirimleri uygulay\u0131n.<\/strong><\/li>\n\n\n\n<li>Kademeli fiyatland\u0131rma modelleri benimseyin.<\/li>\n\n\n\n<li><strong>Fiyatland\u0131rmay\u0131 teorik maksimumlarla de\u011fil, ger\u00e7ek d\u00fcnya de\u011feriyle uyumlu hale getirin.<\/strong><\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Son D\u00fc\u015f\u00fcnceler<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>INESSS&#039;in Agamree&#039;yi reddetmesi, maliyet kontrol\u00fc ile hasta ihtiya\u00e7lar\u0131 aras\u0131ndaki daha derin bir \u00e7at\u0131\u015fman\u0131n alt\u0131n\u0131 \u00e7izmektedir.<\/strong> Vamorolone, kademeli olsa bile, anlaml\u0131 faydalar sunmaktad\u0131r. DMD&#039;li \u00e7ocuklar i\u00e7in daha g\u00fcvenli tedavi se\u00e7enekleri b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r. Ekonomik modeller, ger\u00e7ek d\u00fcnya \u00fczerindeki etkiyi g\u00f6lgede b\u0131rakmamal\u0131d\u0131r. Ayn\u0131 zamanda, fiyatland\u0131rma klinik de\u011feri yans\u0131tmal\u0131d\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Santhera&#039;n\u0131n k\u00fcresel eri\u015filebilirli\u011fi iyile\u015ftirme sorumlulu\u011fu var. Fiyat ayarlamalar\u0131 yap\u0131lmad\u0131\u011f\u0131 s\u00fcrece eri\u015fim s\u0131n\u0131rl\u0131 kalacakt\u0131r.<\/strong> D\u00fczenleyici kurumlar, nadir hastal\u0131klar i\u00e7in \u00e7er\u00e7evelerini uyarlamal\u0131d\u0131r. Maliyet ve bak\u0131m aras\u0131nda denge kurmak i\u00e7in i\u015f birli\u011fi \u015fartt\u0131r. Nihayetinde, hastalar sistemdeki aksakl\u0131klar\u0131n maliyetini \u00fcstlenmemelidir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Sonu\u00e7<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Agamree kusursuz bir ila\u00e7 de\u011fil.<br><strong>Ancak bu, Duchenne kas distrofisi olan \u00e7ocuklar i\u00e7in anlaml\u0131 bir ilerleme ad\u0131m\u0131d\u0131r.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ancak eri\u015fimi tamamen reddetmek, y\u00fck\u00fc sistemin korumakla y\u00fck\u00fcml\u00fc oldu\u011fu ki\u015filerin, yani hastalar\u0131n \u00fczerine kayd\u0131r\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Fiyatland\u0131rma d\u00fczeltilene ve de\u011ferlendirme \u00e7er\u00e7eveleri geli\u015fene kadar, DMD&#039;li \u00e7ocuklar ger\u00e7ekliklerinden \u00e7ok uzak al\u0131nan kararlar\u0131n bedelini \u00f6demeye devam edecekler.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Devam\u0131n\u0131 oku: <a href=\"https:\/\/dmdwarrior.com\/tr\/duchenne-muscular-dystrophy-treatment-cost\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ac\u0131 Ger\u00e7ek: Duchenne Kas Distrofisi Tedavi Maliyetleri Neden Kontrolden \u00c7\u0131kt\u0131?<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>The recent decision by INESSS (Institut national d&#8217;excellence en sant\u00e9 et en services sociaux) in Canada to refuse reimbursement for Agamree (vamorolone) represents more than a bureaucratic outcome\u2014it exposes a systemic failure in balancing economic models with the urgent needs of children living with Duchenne muscular dystrophy (DMD). A Known Disease, A Known Need DMD [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7766,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[282],"tags":[42,171,727,728,41,43],"class_list":["post-7765","post","type-post","status-publish","format-standard","has-post-thumbnail","category-editorials","tag-agamree","tag-canada","tag-inesss","tag-quebec","tag-santhera","tag-vamorolone"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/7765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=7765"}],"version-history":[{"count":2,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/7765\/revisions"}],"predecessor-version":[{"id":7768,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/7765\/revisions\/7768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/7766"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=7765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=7765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=7765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}